Journal List > J Korean Ophthalmol Soc > v.56(9) > 1010074

Lee, Kim, Lim, Choi, and Cho: Clinical Outcomes of Diffractive Aspheric Trifocal Intraocular Lens Implantation

Abstract

Purpose

To evaluate the clinical outcomes of patients with diffractive aspheric trifocal intraocular lens (AT.LISA tri839 MP® IOL, Carl Zeiss Meditec, Jena, Germany) implantation.

Methods

Forty eyes of 53 patients received phacoemulsification and implantation of AT.LISA tri839 MP® IOL (Carl Zeiss Meditec). Uncorrected distant visual acuity (UDVA), uncorrected intermediate visual acuity (UIVA), uncorrected near visual acui-ty (UNVA), refractive values, and defocus curve were evaluated at postoperative 1 month and 3 months. Optical quality was evaluated with the Optical Quality Analysis System (OQAS®, Visiometrics, Castelldefels, Spain).

Results

At the 3-month postoperative follow-up, the mean spherical equivalent was 0.01 ± 0.31 D and the mean UDVA, UIVA and UNVA were 0.023 ± 0.020, 0.155 ± 0.091, and 0.139 ± 0.069, respectively. The means of the objective scatter index, modu-lation transfer function cut-off value, Strehl ratio measured by OQAS® (Visiometrics) were 1.83 ± 0.52, 33.58 ± 14.27 cycle per degree and 0.18 ± 0.11, respectively. Intermediate visual acuity did not fall sharply at defocus curve.

Conclusions

Implantation of the diffractive aspheric trifocal intraocular lens in patients with cataracts provided excellent distant, intermediate and near visual acuities with high visual quality.

References

1. Kim JH, Yu S, Koo SH. . Clinical outcomes of diffractive mul-tifocal toric intraocular lens implantation. J Korean Ophthalmol Soc. 2014; 55:1139–49.
crossref
2. Kim SM, Kim CH, Chung ES, Chung TY. Visual outcome and pa-tient satisfaction after implantation of multifocal IOLs: three-month follow-up results. J Korean Ophthalmol Soc. 2012; 53:230–7.
crossref
3. Kohnen T, Allen D, Boureau C. . European multicenter study of the AcrySof ReSTOR apodized diffractive intraocular lens. Ophthalmology. 2006; 113:584.e1.
crossref
4. Petermeier K, Messias A, Gekeler F. . Outcomes of the Acrysof ReSTOR IOL in myopes, emmetropes, and hyperopes. J Refract Surg. 2009; 25:1103–9.
crossref
5. Petermeier K, Szurman P. Subjective and objective outcome fol-lowing implantation of the apodized diffractive AcrySof ReSTOR. Ophthalmologe. 2007; 104:399–404. 406-8.
6. Law EM, Aggarwal RK, Kasaby H. Clinical outcomes with a new trifocal intraocular lens. Eur J Ophthalmol. 2014; 24:501–8.
crossref
7. Mojzis P, Peña-García P, Liehneova I. . Outcomes of a new dif-fractive trifocal intraocular lens. J Cataract Refract Surg. 2014; 40:60–9.
crossref
8. Kim YJ, Cheon MH, Ko DA. . Visual function and patient sat-isfaction in pseudophakic monovision. J Korean Ophthalmol Soc. 2012; 53:1621–9.
crossref
9. Lee HY, Her J. Clinical evaluation of monovision after cataract surgery. J Korean Ophthalmol Soc. 2008; 49:1437–42.
crossref
10. Kwon JW, Kang S, Chung SK, Baek NH. Clinical results of Crystalens(R) (AT-45) accommodating intraocular lens. J Korean Ophthalmol Soc. 2009; 50:1179–83.
11. Lee HS, Park SH, Kim MS. Clinical results and some problems of multifocal apodized diffractive intraocular lens implantation. J Korean Ophthalmol Soc. 2008; 49:1235–41.
crossref
12. Cumming JS, Slade SG, Chayet A. . Clinical evaluation of the model AT-45 silicone accommodating intraocular lens: results of feasibility and the initial phase of a Food and Drug Administration clinical trial. Ophthalmology. 2001; 108:2005–9.
crossref
13. Nakazawa M, Ohtsuki K. Apparent accommodation in pseudo-phakic eyes after implantation of posterior chamber intraocular lenses. Am J Ophthalmol. 1983; 96:435–8.
crossref
14. Trindade F, Oliveira A, Frasson M. Benefit of against-the-rule as-tigmatism to uncorrected near acuity. J Cataract Refract Surg. 1997; 23:82–5.
crossref
15. Park CW, Lee YE, Joo CK. Changes in optical quality of cataract patients' corrected visual acuity before and after phacoemulsification. J Korean Ophthalmol Soc. 2013; 54:1208–12.
crossref
16. Saad A, Saab M, Gatinel D. Repeatability of measurements with a double-pass system. J Cataract Refract Surg. 2010; 36:28–33.
crossref

Figure 1.
The aspheric diffractive trifocal intraocular lens (AT.LISA tri839 MP®, Carl Zeiss Meditec, Jena, Germany).
jkos-56-1338f1.tif
Figure 2.
Visual acuity after AT.LISA tri839 MP® IOL (Carl Zeiss Meditec, Jena, Germany) implantation. (A) Uncorrected distance visual acuity (UDVA). (B) Uncorrected intermediate visu-al acuity (UIVA). (C) Uncorrected near visual acuity (UNVA).
jkos-56-1338f2.tif
Figure 3.
Mean monocular defocus curve at 1 and 3 months af-ter surgery. PL = plano; D = diopter.
jkos-56-1338f3.tif
Table 1.
Patient demographics and clinical informations
Parameter Values (range)
Age (years) 53.6 ± 7.8 (29, 65)
UDVA (log MAR) 0.55 ± 0.40 (0.10, 1.40)
CDVA (log MAR) 0.28 ± 0.31 (0.10, 1.40)
Manifest sphere (D) -0.11 ± 1.93 (-4.25, 2.25)
Manifest cylinder (D) -0.69 ± 0.54 (-2.0, 0)
Manifest S.E (D) -0.39 ± 1.86 (-4.5, 1.875)
K2-K1 (D) 0.68 ± 0.36 (0, 1.9)
Mean K (D) 44.32 ± 1.48 (40.62, 47.61)
Axial length (mm) 23.83 ± 1.03 (22.53, 26.02)
Mean IOL power (D) 19.02 ± 2.74 (12.5, 22.5)
Preoperative target (D) 0.24 ± 0.17 (0.06, 0.56)

Values are presented as mean ± SD (range). UDVA = uncorrected distant visual acuity; log MAR = logarithm of the minimal angle of resolution; CDVA = corrected distant visu-al acuity; D = diopter; S.E = spherical equivalent; K2-K1= corneal cylinder; K = keratometry; IOL = intraocular lens.

Table 2.
Refractive value and visual acuity at preoperative, postoperative 1 month, and postoperative 3 months
Value p-value
Preop 1 month 3 months Preop vs. 1 month 1 month vs.3 months
Manifest sphere (D) -0.11 ± 1.93 (-4.25, 2.25 5) 10.06 ± 0.25 (-0.75, 0.5) 0.18 ± 0.24 (-0.75, 0.5) 0.826 0.231
Manifest cylinder (D) ) -0.69 ± 0.54 (-2.0, 0) -0.36 ± 0.27 (-0.75, 0) -0.39 ± 0.20 (-0.75, 0) 0.003 0.535
Manifest S.E (D) -0.39 ± 1.86 (-4.5, 1.875 5) -0.07 ± 0.28 (0.75, 0.5) 0.01 ± 0.31 (-0.75, 0.5) 0.626 0.507
UDVA (log MAR) 0.54 ± 0.40 (0.04, 1) 0.025 ± 0.021 (0, 0.155) 0.023 ± 0.020 (0, 0.155) 0.000 0.629
CDVA (log MAR) 0.26 ± 0.29 (0, 1) 0.008 ± 0.018 (0, 0.155) 0.007 ± 0.011 (0, 0.155) 0.000 0.353
UIVA (log MAR) - 0.167 ± 0.086 (0, 0.301) 0.155 ± 0.091 (0, 0.301) - 0.428
UNVA (log MAR) - 0.141 ± 0.069 (0.097, 0.301 1) 0.139 ± 0.069 (0.097, 0.301) - 0.231

Values are presented as mean ± SD (range). Preop = preoperation; D = diopter; S.E = spherical equivalent; UDVA = uncorrected distance visual acuity at 4 m; log MAR = logarithm of the minimal angle of resolution; CDVA = corrected distance visual acuity at 4 m; UIVA = uncorrected intermediate visual acuity at 80 cm distance; UNVA = uncorrected near visual acuity at 40 cm distance.

p-value was acquired from Wilcoxon signed rank test.

Table 3.
OQAS® results at 1 and 3 months after the diffractive IOL implantation
Parameter Values p-value
1 month 3 months
OSI 1.63 ± 0.60 1.83 ± 0.52 0.656
MTF cut-off (C/deg) 31.15 ± 12.54 33.58 ± 14.27 0.822
Strehl ratio 0.17 ± 0.08 0.18 ± 0.11 0.321

Values are presented as mean ± SD unless otherwise indicated. OQAS® = optical quality analysis system (Visiometrics, Castelldefels, Spain); IOL = intraocular lens; OSI = objective scatter index; MTF = modulation transfer function.

p-value was acquired from Wilcoxon signed rank test.

TOOLS
Similar articles